Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has informed the exchanges that it is sending a letter to shareholders who hold shares in physical (paper) form, asking them to update their PAN, contact details, bank account information, nomination, and specimen signature with the company's Registrar and Transfer Agent (Ankit Consultancy Private Limited). This is a routine compliance action following SEBI circulars that require all listed companies to ensure physical folios are fully KYC-compliant. Shareholders with non-compliant folios will not be able to raise grievances or service requests with the RTA, and any dividend, interest, or redemption payments will be made only via electronic mode from April 1, 2024 onwards. No new financial numbers, business update, or corporate action is included in this filing.
This is a routine regulatory compliance communication with no impact on the company's financials or stock price. It only affects shareholders who still hold paper (physical) share certificates and have not yet updated their KYC details, who may face delays in receiving payments or accessing RTA services if they do not act.